HighTower Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1
Closed -$1.98K 3804
2023
Q3
$1.98K Buy
+1
New +$224 ﹤0.01% 3470
2022
Q2
Sell
-2
Closed -$1K 3472
2022
Q1
$1K Buy
+2
New +$491 ﹤0.01% 3374

Other funds holding PODD

HighTower Advisors's PODD Position: Q1 2026 in Review

HighTower Advisors increased its Insulet (PODD) stake by 16% in Q1 2026, buying an estimated $327K and bringing the position to 9,223 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1731.

HighTower Advisors first reported a position in PODD in Q1 2015 and has held it in 27 quarters since. The position peaked at $2.25M in Q4 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • HighTower Advisors held 9,223 shares of Insulet worth $1.94M as of Q1 2026.
  • HighTower Advisors bought 1,302 Insulet shares in Q1 2026, an estimated $327K.
  • Insulet made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #1731 holding.
  • HighTower Advisors first reported a position in Insulet in Q1 2015 and has held it in 27 quarters since.
  • HighTower Advisors's Insulet position peaked at $2.25M in Q4 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.